Simeon George has an estimated net worth of $603 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., Principia Biopharma Inc., Arcellx, Inc., Design Therapeutics, Inc., Nkarta, Inc., CRISPR Therapeutics AG, GENOCEA BIOSCIENCES, INC., eFFECTOR Therapeutics, Inc., HTG MOLECULAR DIAGNOSTICS, INC, Zenas BioPharma, Inc., Odyssey Therapeutics, Inc., and Avalyn Pharma Inc..

2026 was Simeon George's most active year for acquiring shares with 24 total transactions. Simeon George's most active month to acquire stocks was the month of April. 2026 was Simeon George's most active year for disposing of shares, totalling 22 transactions. Simeon George's most active month to dispose stocks was the month of April. 2024 saw Simeon George paying a total of $132,999,994.50 for 8,014,990 shares, this is the most they've acquired in one year. In 2020 Simeon George cashed out on 3,052,433 shares for a total of $298,285,500.00, their largest year based on trade value.